The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
Clinical trial NCT05735028 · UNKNOWN
Trial details
- NCT number
- NCT05735028
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-07
- Primary completion
- 2025-08-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.